Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease - a podcast by JAMA Network

from 2019-11-25T16:00

:: ::

Interview with John Sims, author of Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials

Further episodes of JAMA Neurology Author Interviews

Further podcasts by JAMA Network

Website of JAMA Network